Announcement: MS Research Comms Collaboration

We are excited to announce that MStranslate has established a new science communication collaboration with the Cambridge Clinical Multiple Sclerosis Research Group, based at the University of Cambridge in England.

Many followers of MStranslate will know of this research group through the videos we have published with Dr Will Brown, for example, discussing their work assessing the effectiveness of metformin and clemastine to promote remyelination in people living with multiple sclerosis.

In the video below, our co-founder, Brett Drummond, shares more details about this partnership, including how social media will be used to share the group’s latest study insights, direct from the researchers themselves.

Start following the Cambridge Clinical Multiple Sclerosis Research Group on Facebook by clicking here, or find them on X (formerly Twitter) by searching for @CambridgeMS1.  New YouTube and LinkedIn channels for the group are also on their way, so stay tuned.

PREVIOUS CAMBRIDGE CLINICAL MULTIPLE SCLEROSIS RESEARCH GROUP INSIGHTS

For ease of reference, Dr Brown’s previous contributions to MStranslate are provided below.

Multiple Sclerosis Remyelination Trial Update: Metformin and Clemastine

Published December 21, 2022.

MS Virtual 2020: Remyelination Clinical Trial Results – Bexarotene – Dr Will Brown

Published October 28, 2020

The MStranslate team thanks the Cambridge Clinical Multiple Sclerosis Research group, in particular Professor Alasdair Coles, Dr Will Brown and Dr Nick Cunniffe, for the opportunity to collaborate and we look forward to helping raise awareness of the innovative and important research they are pursuing.

As always, if you have questions for Brett on any aspects of the above videos, please either comment below or join the conversation on our social channels.

You can find us on Facebook, Twitter, YouTube, Instagram and LinkedIn.